Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning

Bone Marrow Transplantation

Volumn 47, Issue 3, 2012, Pages 369-373

  Yoshihara, S ^a   Ikegame, K ^a   Taniguchi, K ^a   Kaida, K ^a   Kim, E H ^b,c   Nakata, J ^a   Kato, R ^a   Inoue, T ^a   Fujioka, T ^a   Tamaki, H ^a   Okada, M ^a   Soma, T ^a   Ogawa, H ^a,c  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

graft failure; haploidentical transplantation; reduced intensity conditioning; salvage transplantation

Indexed keywords

FLUDARABINE; STEROID; THIOTEPA; THYMOCYTE ANTIBODY;

ADULT; ANEURYSM RUPTURE; ARTICLE; CAROTID ARTERY ANEURYSM; CAUSE OF DEATH; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DOSE RESPONSE; DOSIMETRY; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SALVAGE; GRAFT VERSUS HOST REACTION; HUMAN; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; STEM CELL TRANSPLANTATION; SYNDROME DELINEATION; THERAPY EFFECT; TREATMENT FAILURE; WHOLE BODY RADIATION;

ADULT; ANIMALS; ANTILYMPHOCYTE SERUM; CAROTID ARTERIES; FEMALE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROBABILITY; RABBITS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; THIOTEPA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE;

EID: 84858075229     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.84     Document Type: Article

References (30)

1. Donohue J, Homge M, Kernan NA. Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Blood 1993; 82: 1023-1029. (Pubitemid 23221691)
2. Martin PJ, Akatsuka Y, Hahne M, Sale G. Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 1998; 92: 2177-2181. (Pubitemid 28446710)
3. Ottinger HD, Rebmann V, Pfeiffer KA, Beelen DW, Kremens B, Runde V et al. Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation. Transplantation 2002; 73: 1280-1285. (Pubitemid 34454276)
4. Taylor PA, Ehrhardt MJ, Roforth MM, Swedin JM, Panoskaltsis-Mortari A, Serody JS et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood 2007; 109: 1307-1315. (Pubitemid 46220684)
5. Quinones RR. Hematopoietic engraftment and graft failure after bone marrow transplantation. Am J Pediatr Hematol Oncol 1993; 15: 3-17. (Pubitemid 23061706)
6. Steffens HP, Podlech J, Kurz S, Angele P, Dreis D, Reddehase MJ. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J Virol 1998; 72: 5006-5015. (Pubitemid 28215681)
7. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390-3400.
8. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66: 664-672. (Pubitemid 15230774)
9. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-1822. (Pubitemid 32538694)
10. Baron F, Maris MB, Storer BE, Sandmaier BM, Panse JP, Chauncey TR et al. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. Leukemia 2005; 19: 822-828. (Pubitemid 40663103)
11. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197-204. (Pubitemid 19034144)
12. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275. (Pubitemid 39552742)
13. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285. (Pubitemid 39552743)
14. McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 1994; 13: 233-237.
15. Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol 2000; 111: 292-302.
16. Platzbecker U, Binder M, Schmid C, Rutt C, Ehninger G, Bornhauser M. Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation. Haematologica 2008; 93: 1276-1278.
17. Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM et al. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant 2010; 16: 1099-1106.
18. Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006; 12: 1073-1084.
19. Tamaki H, Ikegame K, Kawakami M, Fujioka T, Tsuboi A, Oji Y et al. Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin. Leukemia 2003; 17: 2052-2054. (Pubitemid 37322138)
20. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
21. Waki F, Masuoka K, Fukuda T, Kanda Y, Nakamae M, Yakushijin K et al. Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of 80 adult patients. Biol Blood Marrow Transplant 2010 (e-pub ahead of print 16 September 2010).
22. Kim EH, Ikegame K, Kawakami M, Nishida S, Fujioka T, Taniguchi Y et al. Unmanipulated reduced-intensity stem cell transplantation from a haploidentical donor mismatched at 3 HLA antigens to a patient with leukemic transformation of myelodysplastic syndrome: successful second transplantation after graft rejection. Int J Hematol 2004; 80: 449-452. (Pubitemid 40053628)
23. Xu LP, Huang XJ. Successful second transplantation from haploidentical donor for graft failure following unrelated cord blood cell transplantation or mismatched related transplantation: 2 cases report. Chin Med J (Engl) 2006; 119: 1489-1493.
24. Lang P, Mueller I, Greil J, Bader P, Schumm M, Pfeiffer M et al. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. Blood Cells Mol Dis 2008; 40: 33-39. (Pubitemid 350192310)
25. Fernandes J, Rocha V, Robin M, de Latour RP, Traineau R, Devergie A et al. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol 2007; 137: 248-251. (Pubitemid 46537638)
26. Jabbour E, Rondon G, Anderlini P, Giralt SA, Couriel DR, Champlin RE et al. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. Bone Marrow Transplant 2007; 40: 431-435. (Pubitemid 47288221)
27. Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN et al. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biol Blood Marrow Transplant 2007; 13: 1313-1323. (Pubitemid 47571031)
28. Byrne BJ, Horwitz M, Long GD, Gasparetto C, Sullivan KM, Chute J et al. Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. Bone Marrow Transplant 2008; 41: 39-43.
29. Bolanos-Meade J, Luznik L, Muth M, Matsui WH, Huff CA, Smith BD et al. Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. Bone Marrow Transplant 2009; 43: 477-480.
30. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006; 108: 1485-1491. (Pubitemid 44316112)